Cargando…
Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis
BACKGROUND: A subanalysis of a randomized clinical trial indicated sepsis survival benefit from interleukin (IL)-1 blockade in patients with features of the macrophage activation-like syndrome (MALS). This study aimed to investigate the frequency of MALS and to develop a biomarker of diagnosis and p...
Autores principales: | Kyriazopoulou, Evdoxia, Leventogiannis, Konstantinos, Norrby-Teglund, Anna, Dimopoulos, Georgios, Pantazi, Aikaterini, Orfanos, Stylianos E., Rovina, Nikoletta, Tsangaris, Iraklis, Gkavogianni, Theologia, Botsa, Elektra, Chassiou, Eleftheria, Kotanidou, Anastasia, Kontouli, Christina, Chaloulis, Panagiotis, Velissaris, Dimitrios, Savva, Athina, Cullberg, Jonas-Sundén, Akinosoglou, Karolina, Gogos, Charalambos, Armaganidis, Apostolos, Giamarellos-Bourboulis, Evangelos J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603161/ https://www.ncbi.nlm.nih.gov/pubmed/28918754 http://dx.doi.org/10.1186/s12916-017-0930-5 |
Ejemplares similares
-
The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort
por: Karakike, Eleni, et al.
Publicado: (2019) -
Soluble fms-like tyrosine kinase 1, placental growth factor and procalcitonin as biomarkers of gram-negative sepsis: Analysis through a derivation and a validation cohort
por: Vittoros, Vasileios, et al.
Publicado: (2021) -
Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2022) -
Resistin in severe bacterial infections
por: Johansson, Linda, et al.
Publicado: (2007) -
Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial
por: Leventogiannis, Konstantinos, et al.
Publicado: (2022)